Clinical Trials Browser

Phase 2 × Completed × Immunotherapy, Adoptive × Clear all

NCT03068416 2021-10-20

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell